In a significant policy reversal, the National Institute for Health and Care Excellence (NICE) has recommended abiraterone for adults with newly diagnosed high-risk metastatic prostate cancer, ...

President Donald Trump’s razing of the White House’s East Wing to build a ballroom has put some news organizations following the story in an awkward position, with corporate owners among ...

TERAGO Inc. ("TERAGO" or the "Company") ( Canada's largest mmWave spectrum holder (91% of spectrum held) and a leading provider of Managed Fixed Wireless Internet, 5G Private Wireless Networks and ...

ADT reported higher Q3 earnings and cash flow driven by ADT+ adoption and operational discipline, even as attrition edged up ...

ADT Inc. (ADT) on Tuesday reported third-quarter net income of $145 million. On a per-share basis, the Boca Raton, Florida-based company said it had ...

Is facial recognition the future of home security? With ADT’s Trusted Neighbor feature, you can provide controlled, ...

Google’s home security partner, ADT, has a big discount available for anyone looking to start off a new security ...

What Happened? Shares of security technology and services company ADT (NYSE:ADT) fell 6.2% in the morning session after it ...

NICE recommends Bayer’s Nubeqa® (darolutamide) plus androgen deprivation therapy as a treatment option for patients with hormone-sensitive metastatic prostate cancer Nubeqa® (darolutamide) plus ...

The General reports that car ownership costs are surging due to inflation, insurance hikes, and rising repair expenses, ...

Novartis has shared detailed data showing its radioligand therapy Pluvicto could slow the progression of certain hormone-sensitive prostate cancers ahead of a planned application with the FDA.

Darolutamide, also known as Nubeqa and made by Bayer, is recommended in final draft guidance to treat adults with metastatic hormone-sensitive prostate cancer in combination with androgen deprivation ...